- Home
- NBTX vs UAMY Comparison
NBTX vs UAMY Comparison
Compare NBTX & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- UAMY
- Stock Information
- Founded
- NBTX 2003
- UAMY 1968
- Country
- NBTX France
- UAMY United States
- Employees
- NBTX N/A
- UAMY N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- UAMY Metal Fabrications
- Sector
- NBTX Health Care
- UAMY Industrials
- Exchange
- NBTX Nasdaq
- UAMY Nasdaq
- Market Cap
- NBTX 201.9M
- UAMY 206.0M
- IPO Year
- NBTX 2020
- UAMY N/A
- Fundamental
- Price
- NBTX $3.75
- UAMY $1.57
- Analyst Decision
- NBTX Strong Buy
- UAMY Strong Buy
- Analyst Count
- NBTX 1
- UAMY 2
- Target Price
- NBTX $12.00
- UAMY $1.75
- AVG Volume (30 Days)
- NBTX 8.9K
- UAMY 2.2M
- Earning Date
- NBTX 09-18-2024
- UAMY 04-11-2025
- Dividend Yield
- NBTX N/A
- UAMY N/A
- EPS Growth
- NBTX N/A
- UAMY N/A
- EPS
- NBTX N/A
- UAMY N/A
- Revenue
- NBTX $45,220,186.00
- UAMY $10,219,826.00
- Revenue This Year
- NBTX N/A
- UAMY $62.73
- Revenue Next Year
- NBTX N/A
- UAMY $194.39
- P/E Ratio
- NBTX N/A
- UAMY N/A
- Revenue Growth
- NBTX 526.17
- UAMY 28.40
- 52 Week Low
- NBTX $2.76
- UAMY $0.17
- 52 Week High
- NBTX $7.51
- UAMY $2.35
- Technical
- Relative Strength Index (RSI)
- NBTX 53.25
- UAMY 42.03
- Support Level
- NBTX $3.60
- UAMY $1.79
- Resistance Level
- NBTX $3.95
- UAMY $2.09
- Average True Range (ATR)
- NBTX 0.19
- UAMY 0.15
- MACD
- NBTX -0.01
- UAMY -0.04
- Stochastic Oscillator
- NBTX 38.18
- UAMY 3.70
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has four operating segments: United States Antimony, Mexican antimony, zeolite, and Precious metals. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.